Myomo Inc. (MYO)

NYSEAMERICAN: MYO · IEX Real-Time Price · USD
2.29
-0.12 (-4.98%)
May 20, 2022 4:00 PM EDT - Market closed
Market Cap15.76M
Revenue (ttm)15.39M
Net Income (ttm)-10.87M
Shares Out6.88M
EPS (ttm)-1.74
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume17,691
Open2.40
Previous Close2.41
Day's Range2.26 - 2.49
52-Week Range2.26 - 14.35
Beta1.07
AnalystsBuy
Price Target18.36 (+701.7%)
Earnings DateMay 11, 2022

About MYO

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cor...

IndustryHealth Care Equipment & Supplies
IPO DateJun 12, 2017
CEOPaul Gudonis
Employees87
Stock ExchangeNYSEAMERICAN
Ticker SymbolMYO
Full Company Profile

Financial Performance

In 2021, Myomo's revenue was $13.86 million, an increase of 82.72% compared to the previous year's $7.58 million. Losses were -$10.37 million, -10.30% less than in 2020.

Financial Statements

Analyst Forecast

According to 7 analysts, the average rating for MYO stock is "Buy." The 12-month stock price forecast is 18.36, which is an increase of 701.75% from the latest price.

Price Target
$18.36
(701.75% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Myomo, Inc. (MYO) Reports Q1 Loss, Tops Revenue Estimates

Myomo, Inc. (MYO) delivered earnings and revenue surprises of 24.07% and 35.72%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

1 week ago - Zacks Investment Research

Myomo Reports First Quarter 2022 Financial Results

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disord...

1 week ago - Business Wire

Myomo to Report First Quarter Financial Results on May 11, 2022

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disord...

2 weeks ago - Business Wire

Myomo Reports Progress with China Joint Venture, Receives Partial Payment of Technology License Fee

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disord...

1 month ago - Business Wire

Myomo, Inc. (MYO) Reports Q4 Loss, Tops Revenue Estimates

Myomo, Inc. (MYO) delivered earnings and revenue surprises of -6.12% and 34.36%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Myomo To Participate in Two March Investor Conferences

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disord...

2 months ago - Business Wire

Myomo Reports Fourth Quarter and Full Year 2021 Financial Results

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disord...

2 months ago - Business Wire

Myomo to Report Fourth Quarter and Full Year 2021 Financial Results on March 9, 2022

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disord...

2 months ago - Business Wire

Myomo Strengthens Intellectual Property Portfolio With Receipt of Key Patent in Japan

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disord...

3 months ago - Business Wire

Independent Research with Myomo's MyoPro® Shows Clinically Significant Gains in Motor Function in Individuals with Ch...

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disord...

3 months ago - Business Wire

Myomo to Present at the Sidoti Winter Small Cap Conference

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disord...

4 months ago - Business Wire

Myomo Provides Update on MyoPro® Insurance Reimbursement

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disord...

4 months ago - Business Wire

Myomo Announces MyoPro® 2+

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disord...

4 months ago - Business Wire

Myomo Amends China Joint Venture Agreement, Executes Technology and Trademark License Agreement

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disord...

4 months ago - Business Wire

Myomo, Inc. (MYO) Reports Q3 Loss, Tops Revenue Estimates

Myomo, Inc. (MYO) delivered earnings and revenue surprises of 23.40% and 40.06%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

Myomo Third Quarter 2021 Financial Results Feature Record Revenue

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disord...

6 months ago - Business Wire

Myomo to Report Third Quarter 2021 Financial Results on November 10, 2021

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disord...

6 months ago - Business Wire

Will Myomo, Inc. (MYO) Report Negative Q3 Earnings? What You Should Know

Myomo, Inc. (MYO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

6 months ago - Zacks Investment Research

Myomo, Inc. Announces Agreements for Exercise of 2020 Investor Warrants

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disord...

7 months ago - Business Wire

Myomo, Inc. to Present at Fall Harvest - Best Ideas from the Buy-Side on October 5th

BOSTON, MA / ACCESSWIRE / September 28, 2021 / Myomo, Inc. (NYSE American:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering fro...

7 months ago - Accesswire

Myomo, Inc. Announces Granting of Patents in China and Hong Kong

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disord...

8 months ago - Business Wire

Myomo, Inc. Announces Participation in Three September Investment Conferences

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American:MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorde...

8 months ago - Business Wire

Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates

Myomo, Inc. (MYO) delivered earnings and revenue surprises of 25.81% and 51.86%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

9 months ago - Zacks Investment Research

Myomo Second Quarter 2021 Financial Results Feature Significant Increases in Revenue and Gross Margin, Record Insuran...

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disord...

9 months ago - Business Wire

Myomo, Inc. (MYO) May Report Negative Earnings: Know the Trend Ahead of Q2 Release

Myomo, Inc. (MYO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

9 months ago - Zacks Investment Research